Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)

NCT00127114 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding and exclusion criteria were to stringent.

Conditions

Dementia

Interventions

DRUG: Amantadine
DRUG: Placebo

Sponsor

Johns Hopkins University